Next Generation Sequencing (NGS) Market Poised to Hit $42.25 Billion by 2033: Key Drivers Behind the Surge - Latest Study by Grand View Research, Inc.
Without question, next-generation sequencing (NGS) has been immensely successful, even if it hasn’t transformed medicine just yet. Sequencing itself has become nearly trivial. Declining costs have ...
The company in Carlsbad CA and the TELL-Seq kit TELL-Meta software pipeline will revolutionize metagenomics research with Linked read for new species discovery, high quality metagenomic assembly and ...
ST. LOUIS--(BUSINESS WIRE)--Appistry, a leading provider of solutions that simplify the analysis of next-generation sequencing (NGS) data, announced today integrated solutions that automate NGS ...
Genomatix Software, a leading provider of complete solutions for the analysis of Next Generation Sequencing (NGS) data, announced today that the European Molecular Biology Laboratory (EMBL) installed ...
Many factors drive the next-generation sequencing (NGS) market in regulated environments. Only a few years ago, the throughput and price point did not allow for easy transition from existing ...
When the Precision Medicine Initiative was launched in 2015, it completely transformed patient care in oncology. Now, individual differences in genetics, environment and lifestyle, along with the ...
Munich (Germany), Ann Arbor, MI (USA) – March 10, 2010 - The C.S. Mott Center for Human Growth and Development, Department of Obstetrics and Gynecology, at the Wayne State University School of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback